China Medicine Corp. is a developer and leading distributor of prescription and over-the-counter drugs, traditional Chinese medicine products, nutritional and dietary supplements, and medical devices and formulations in China.

The company announced today that through its wholly-owned subsidiary in China, Konzern Pharmaceuticals, it has signed an equity transfer agreement to acquire 100% of equity interests in Sinoform Limited, a British Virgin Islands corporation which is the sole shareholder of Guangzhou LifeTech Pharmaceuticals. LifeTech Pharmaceuticals is a developer, manufacturer and marketer of pharmaceutical products and traditional Chinese medicines in China.

The acquisition is expected to close before the end of the year and China Medicine will acquire Guangzhou LifeTech for 57 million renminbi or about $8.3 million cash and the assumption of about $13.2 million in debt. Upon closing of the acquisition, the company will receive all of LifeTech’s assets, including a portfolio of 39 Western and traditional Chinese medicine products. LifeTech’s top-selling

Understanding your customer base may seem like an obvious statement in the manufacturing world. Unfortunately, the statement is all too often ignored. When a cultural aspect is added into the equation, understanding cultural needs and requirements becomes even more of an imperative as ignoring it will ultimately doom a project. If, however, a company can blend the two, it will have a solid chance at substantial profit right along with a savvy investor.

Tiens Biotech Group Inc. USA., a nutritional products company, works to develop, manufacture and market dietary supplements and wellness products primarily in China, the Russian Federation, Ukraine, Vietnam and India. Its products are offered in powder, soft gel capsule, grain and tablet forms. The company is a subsidiary of the Tianshi International Group Inc., a Delaware registered company operating in China.

The company recently reported solid results for the first three months of 2009. Net income increased from $4.4

DrStockPick.com Stock Report!

Friday August 14, 2009

**************************************************************

On August 13, 2009, Federman & Sherwood filed the first class action lawsuit in the United States District Court for the Southern District of New York against MIND C.T.I., Ltd. (NASDAQ: MNDO). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, as more specifically set forth below. The class period is from June 8, 2006 through February 27, 2008.

Badger Meter, Inc. (NYSE: BMI) today announced a 9.1% increase in its quarterly common stock dividend to 12 cents per share from 11 cents per share. The increased dividend is payable

GNC has more than 4,800 retail locations throughout the United States (including more than 1,000 franchise and 1,200 Rite Aid store-within-a-store locations) and franchise operations in 48 international markets.

Leading sports nutrition company PacificHealth Laboratories Inc. today announced that its scientifically proven appetite management tool, ForzeGPS, which hit the shelves of 1,500 GNC stores in March, is now available in more than 1,750 specialty retail stores nationwide.

PacificHealth’s ForzeGPS line of products was designed specifically for athletes seeking ways to improve their bodies’ potential speed and performance. The all-natural nutrition bars and drinks center on a multi-patented blend of healthy fats, protein and calcium.

“Quite simply, ForzeGPS addresses the problem of excess calorie intake driven by hunger by satisfying one’s appetite in a calorie-efficient manner, and perhaps as importantly for the business’ performance, in a more consumer friendly and more broadly appealing (single serve) format,” Jason Ash, president and

Bio-Solutions Corp. focuses on veterinary care and organic dietary supplements for livestock and domestic animals. The company announced last week it will market an organic insecticide to combat Malaria.

GreenExTM is available in solid or liquid form, and works by neutralizing and eradicating up to 98 percent of mosquito larvae within a 24-hour period. Malaria is a life threatening disease, infecting more than 250 million people each year and killing more than 1 million children under the age of five each year. The disease isn’t geographically restricted, but thrives in tropical and subtropical regions. According to the company, GreenExTM can be used for humans, as well as animals.

“This organic product can be as useful in veterinary care as for human care; Bio-Solutions will advocate a specialized market strategy for GreenExTM. We will offer this product as a viable alternative to the countries dissatisfied of the service offered by the